ADA boycott explained: Scientists speak out over censorship and accountability failures

More than 1,100 members and supporters of the American Diabetes Association (ADA) are boycotting the organization — and the flagship journal Diabetes Care has stopped accepting submissions — following a dramatic incident at the ADA's June 2026 annual scientific meeting in New Orleans. Five physicians and scientists were removed by armed security and threatened with arrest after distributing reprints of a published editorial criticizing Trump administration cuts to NIH funding. The ADA had previously required the editorial's authors to add disclaimers before publication.

Since then, the ADA has offered conflicting explanations for the removal, censored first-hand accounts and opinion pieces from those involved (including former board members), and conducted an internal "independent" review chaired by its own board members. The review initially concluded the five attendees "disrupted the event" — before the ADA reversed course days later with a second press release citing additional findings.

Key Takeaways:

• The boycott has halted grant reviews, fundraisers, educational activities, and annual meeting planning
• Diabetes Care editorial board meetings were quietly cancelled by the ADA following the conference
• A separate editorial on scientific freedom, accepted by another ADA journal, was also censored
• Critical questions remain unanswered: Who authorized armed security? Why were the expelled scientists' outreach ignored? Why was editorial content suppressed?

Why it matters: The ADA shapes clinical guidelines, national diabetes policy, and research priorities. This standoff raises urgent questions about scientific freedom, editorial independence, and accountability within major medical societies — with implications that extend well beyond diabetes care.